Finance

The surprising story behind European IPOs

Wednesday 12 September 2012

Interviewee/Contributer: Bernd Muehlenweg

Organisation: Nanobiotix SA

Full text available to subscribers only. Click here for information on subscribing to MedNous.

The quest for a cure for Parkinson's disease

Monday 18 June 2012

Interviewee/Contributer: Todd Sherer

Organisation: Michael J Fox Foundation

Full text available to subscribers only. Click here for information on subscribing to MedNous.

A new venture capital model

Sunday 20 May 2012

Interviewee/Contributer: Kevin Johnson

Organisation: Index Ventures Management LLP

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Interview: 4-Antibody AG - How do you structure a biotech for divestment?

Friday 27 April 2012

Interviewee/Contributer: Robert Burns

Organisation: 4-Antibody AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

A Big Pharma deal that shares risk and reward

Friday 27 April 2012

Interviewee/Contributer: Bahija Jallal

Organisation: MedImmune

Full text available to subscribers only. Click here for information on subscribing to MedNous.

European biotechs rebound sharply

Friday 27 April 2012

Interviewee/Contributer: William Ellington

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Due diligence is more than a numbers game

Friday 27 April 2012

Interviewee/Contributer: Anthony Sedgwick

Organisation: Silence Therapeutics Plc

Full text available to subscribers only. Click here for information on subscribing to MedNous.

The role of technology providers in biotech

Friday 24 February 2012

Interviewee/Contributer: John Burt

Organisation: PolyTherics Ltd

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Making the most of EU funding

Thursday 20 October 2011

Interviewee/Contributer: Karen Finn

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

$2 billion in new US funding

Friday 10 September 2010

Interviewee/Contributer: 

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content